Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2004

View Archived Issues

OSI Pharmaceuticals reports portfolio highlights from Q1 2004

MedImmune highlights 2003 developments

Further evidence for the antiovulatory effects of CDB-2914 in healthy women

Allergan updates Q4 2003 product and pipeline developments

Abbott to evaluate Raven's monoclonal antibodies in new collaboration

EntreMed transfers endostatin and angiostatin rights

Adderall XR available in Canada

Tillotts and Zeria sign Japanese agreement for Asacol

Pharmacopeia and Taiho collaborate on drug discovery efforts

Abbott and Caprion collaborate on drug discovery for lung cancer

The SPORTIF trials provide new data on ximelagatran in the prevention of stroke

First phase I results reported for Ono-2506 in the management of ischemic stroke

Clinical improvements found with CP-101606 in acute ischemic stroke

Phase II clinical results on the efficacy and safety of DP-b99 in acute stroke

Preclinical and clinical evidence of the benefits of repinotan in ischemia

Selective and dual PPARalpha/PPARgamma agonists developed at AstraZeneca

NO-releasing COX-2 inhibitors in early development at NicOx

Another series of HCV NS5B inhibitors presented by Merck and Isis researchers

Novel pyridazine-based PDE4 inhibitors covered by Merck KGaA patent

Lilly presents new selective and dual PPAR modulators

Pfizer claims new MMP-13 inhibitors with utility in inflammatory disorders and cancer

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

New PDE5 inhibitors claimed by Janssen scientists

NanoPass and GlaxoSmithKline to develop MicroPyramid vaccine technology

Nuvelo licenses rNAPc from Dendreon

DepoCyte launched in Europe

New clinical program for maribavir in prevention of CMV in transplants

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Alimta approved for use with cisplatin for malignant pleural mesothelioma

AP-5346 makes preclinical and clinical progress

Orthovisc receives FDA approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...